Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

Europe - BIT:DEX - IT0005543480 - Common Stock

6.3 EUR
+0.04 (+0.64%)
Last: 10/20/2025, 4:16:41 PM
Fundamental Rating

4

Taking everything into account, DEX scores 4 out of 10 in our fundamental rating. DEX was compared to 34 industry peers in the Household Durables industry. DEX has an average financial health and profitability rating. DEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
DEX had a positive operating cash flow in the past year.
Of the past 5 years DEX 4 years were profitable.
In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.20%, DEX is in line with its industry, outperforming 55.88% of the companies in the same industry.
With a Return On Equity value of 5.87%, DEX perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
DEX's Return On Invested Capital of 3.48% is in line compared to the rest of the industry. DEX outperforms 47.06% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DEX is below the industry average of 10.91%.
The last Return On Invested Capital (3.48%) for DEX is well below the 3 year average (7.89%), which needs to be investigated, but indicates that DEX had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROIC 3.48%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

DEX has a Profit Margin (1.97%) which is comparable to the rest of the industry.
DEX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 2.98%, DEX is in line with its industry, outperforming 50.00% of the companies in the same industry.
DEX's Operating Margin has declined in the last couple of years.
DEX has a Gross Margin of 37.82%. This is comparable to the rest of the industry: DEX outperforms 50.00% of its industry peers.
DEX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

4

2. Health

2.1 Basic Checks

DEX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, DEX has less shares outstanding
Compared to 1 year ago, DEX has an improved debt to assets ratio.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DEX has an Altman-Z score of 1.85. This is not the best score and indicates that DEX is in the grey zone with still only limited risk for bankruptcy at the moment.
DEX has a Altman-Z score (1.85) which is comparable to the rest of the industry.
DEX has a debt to FCF ratio of 23.75. This is a negative value and a sign of low solvency as DEX would need 23.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 23.75, DEX is in line with its industry, outperforming 44.12% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that DEX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.34, DEX is in line with its industry, outperforming 58.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Altman-Z 1.85
ROIC/WACC0.54
WACC6.41%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

DEX has a Current Ratio of 1.06. This is a normal value and indicates that DEX is financially healthy and should not expect problems in meeting its short term obligations.
DEX's Current ratio of 1.06 is on the low side compared to the rest of the industry. DEX is outperformed by 76.47% of its industry peers.
DEX has a Quick Ratio of 1.06. This is a bad value and indicates that DEX is not financially healthy enough and could expect problems in meeting its short term obligations.
DEX's Quick ratio of 0.75 is in line compared to the rest of the industry. DEX outperforms 41.18% of its industry peers.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.75
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

The earnings per share for DEX have decreased strongly by -65.75% in the last year.
DEX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.38% yearly.
The Revenue has grown by 9.70% in the past year. This is quite good.
DEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.04% yearly.
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%

3.2 Future

The Earnings Per Share is expected to grow by 1.45% on average over the next years.
The Revenue is expected to grow by 6.12% on average over the next years.
EPS Next Y-34.28%
EPS Next 2Y-3.67%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue Next Year6.58%
Revenue Next 2Y7.02%
Revenue Next 3Y6.12%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.09, DEX is valued on the expensive side.
Based on the Price/Earnings ratio, DEX is valued a bit cheaper than 64.71% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.42, DEX is valued a bit cheaper.
A Price/Forward Earnings ratio of 7.94 indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 76.47% of the companies listed in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.09
Fwd PE 7.94
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 70.59% of the companies listed in the same industry.
DEX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 47.56
EV/EBITDA 5.92
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.67%
EPS Next 3Y1.45%

0

5. Dividend

5.1 Amount

DEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DEXELANCE SPA

BIT:DEX (10/20/2025, 4:16:41 PM)

6.3

+0.04 (+0.64%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.92%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap169.66M
Analysts85.71
Price Target10.37 (64.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-24.43%
EPS NY rev (3m)-43.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE 19.09
Fwd PE 7.94
P/S 0.35
P/FCF 47.56
P/OCF 16.13
P/B 1.05
P/tB N/A
EV/EBITDA 5.92
EPS(TTM)0.33
EY5.24%
EPS(NY)0.79
Fwd EY12.6%
FCF(TTM)0.13
FCFY2.1%
OCF(TTM)0.39
OCFY6.2%
SpS17.87
BVpS6
TBVpS-2.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.2%
ROE 5.87%
ROCE 4.78%
ROIC 3.48%
ROICexc 3.89%
ROICexgc 22.15%
OM 2.98%
PM (TTM) 1.97%
GM 37.82%
FCFM 0.74%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 23.75
Debt/EBITDA 1.49
Cap/Depr 30.32%
Cap/Sales 1.44%
Interest Coverage 250
Cash Conversion 28.23%
Profit Quality 37.61%
Current Ratio 1.06
Quick Ratio 0.75
Altman-Z 1.85
F-Score7
WACC6.41%
ROIC/WACC0.54
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.75%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-825%
EPS Next Y-34.28%
EPS Next 2Y-3.67%
EPS Next 3Y1.45%
EPS Next 5YN/A
Revenue 1Y (TTM)9.7%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%2.53%
Revenue Next Year6.58%
Revenue Next 2Y7.02%
Revenue Next 3Y6.12%
Revenue Next 5YN/A
EBIT growth 1Y-62.21%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year18.43%
EBIT Next 3Y13.06%
EBIT Next 5YN/A
FCF growth 1Y-74.95%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y-42.38%
OCF growth 3Y11.3%
OCF growth 5YN/A